ConvaTec Group Plc
ConvaTec Group Plc CNVVF Peers
See (CNVVF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CNVVF | $3.13 | +4.33% | 6.4B | 34.78 | $0.09 | +2.02% |
| SRTOY | $21.39 | +1.91% | 208.1B | 89.13 | $0.24 | +0.31% |
| ESLOF | $277.77 | -0.88% | 126.9B | 47.56 | $5.84 | +1.39% |
| ESLOY | $139.23 | -1.16% | 126.8B | 47.68 | $2.92 | +1.40% |
| MECNY | $88.63 | +100.00% | 107.8B | N/A | N/A | N/A |
| SSSGY | $42.11 | -0.94% | 76.7B | 135.84 | $0.31 | +0.41% |
| SOAGY | $48.65 | -1.37% | 76.4B | 156.94 | $0.31 | +0.15% |
| HOCPF | $121.77 | -2.35% | 41.4B | 29.41 | $4.14 | +0.87% |
| HOCPY | $117.60 | -2.86% | 40.5B | 28.54 | $4.12 | +0.43% |
| RSMDF | $23.35 | +6.14% | 28B | 26.24 | $0.89 | +0.87% |
Stock Comparison
CNVVF vs SRTOY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SRTOY has a market cap of 208.1B. Regarding current trading prices, CNVVF is priced at $3.13, while SRTOY trades at $21.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SRTOY's P/E ratio is 89.13. In terms of profitability, CNVVF's ROE is +0.16%, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, CNVVF and SRTOY have similar daily volatility (0.00).
CNVVF vs ESLOF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, ESLOF has a market cap of 126.9B. Regarding current trading prices, CNVVF is priced at $3.13, while ESLOF trades at $277.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas ESLOF's P/E ratio is 47.56. In terms of profitability, CNVVF's ROE is +0.16%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, CNVVF is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs ESLOY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, ESLOY has a market cap of 126.8B. Regarding current trading prices, CNVVF is priced at $3.13, while ESLOY trades at $139.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas ESLOY's P/E ratio is 47.68. In terms of profitability, CNVVF's ROE is +0.16%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, CNVVF is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs MECNY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, MECNY has a market cap of 107.8B. Regarding current trading prices, CNVVF is priced at $3.13, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas MECNY's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, CNVVF and MECNY have similar daily volatility (0.00).
CNVVF vs SSSGY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SSSGY has a market cap of 76.7B. Regarding current trading prices, CNVVF is priced at $3.13, while SSSGY trades at $42.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SSSGY's P/E ratio is 135.84. In terms of profitability, CNVVF's ROE is +0.16%, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, CNVVF and SSSGY have similar daily volatility (0.00).
CNVVF vs SOAGY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SOAGY has a market cap of 76.4B. Regarding current trading prices, CNVVF is priced at $3.13, while SOAGY trades at $48.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SOAGY's P/E ratio is 156.94. In terms of profitability, CNVVF's ROE is +0.16%, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, CNVVF is less volatile compared to SOAGY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs HOCPF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, HOCPF has a market cap of 41.4B. Regarding current trading prices, CNVVF is priced at $3.13, while HOCPF trades at $121.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas HOCPF's P/E ratio is 29.41. In terms of profitability, CNVVF's ROE is +0.16%, compared to HOCPF's ROE of +0.15%. Regarding short-term risk, CNVVF is less volatile compared to HOCPF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs HOCPY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, HOCPY has a market cap of 40.5B. Regarding current trading prices, CNVVF is priced at $3.13, while HOCPY trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas HOCPY's P/E ratio is 28.54. In terms of profitability, CNVVF's ROE is +0.16%, compared to HOCPY's ROE of +0.15%. Regarding short-term risk, CNVVF is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs RSMDF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, RSMDF has a market cap of 28B. Regarding current trading prices, CNVVF is priced at $3.13, while RSMDF trades at $23.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas RSMDF's P/E ratio is 26.24. In terms of profitability, CNVVF's ROE is +0.16%, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, CNVVF and RSMDF have similar daily volatility (0.00).
CNVVF vs TRUMF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TRUMF has a market cap of 27.6B. Regarding current trading prices, CNVVF is priced at $3.13, while TRUMF trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TRUMF's P/E ratio is 34.06. In terms of profitability, CNVVF's ROE is +0.16%, compared to TRUMF's ROE of +0.07%. Regarding short-term risk, CNVVF is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs TRUMY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TRUMY has a market cap of 27.2B. Regarding current trading prices, CNVVF is priced at $3.13, while TRUMY trades at $18.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TRUMY's P/E ratio is 33.31. In terms of profitability, CNVVF's ROE is +0.16%, compared to TRUMY's ROE of +0.07%. Regarding short-term risk, CNVVF is less volatile compared to TRUMY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs CLPBY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, CLPBY has a market cap of 22B. Regarding current trading prices, CNVVF is priced at $3.13, while CLPBY trades at $9.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas CLPBY's P/E ratio is 31.10. In terms of profitability, CNVVF's ROE is +0.16%, compared to CLPBY's ROE of +0.27%. Regarding short-term risk, CNVVF is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs CLPBF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, CLPBF has a market cap of 21.9B. Regarding current trading prices, CNVVF is priced at $3.13, while CLPBF trades at $97.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas CLPBF's P/E ratio is 31.67. In terms of profitability, CNVVF's ROE is +0.16%, compared to CLPBF's ROE of +0.27%. Regarding short-term risk, CNVVF and CLPBF have similar daily volatility (0.00).
CNVVF vs SDMHF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SDMHF has a market cap of 21.1B. Regarding current trading prices, CNVVF is priced at $3.13, while SDMHF trades at $216.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SDMHF's P/E ratio is 90.27. In terms of profitability, CNVVF's ROE is +0.16%, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, CNVVF and SDMHF have similar daily volatility (0.00).
CNVVF vs SAUHY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SAUHY has a market cap of 20.6B. Regarding current trading prices, CNVVF is priced at $3.13, while SAUHY trades at $12.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SAUHY's P/E ratio is 36.89. In terms of profitability, CNVVF's ROE is +0.16%, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, CNVVF is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs SAUHF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SAUHF has a market cap of 20.5B. Regarding current trading prices, CNVVF is priced at $3.13, while SAUHF trades at $128.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SAUHF's P/E ratio is 37.10. In terms of profitability, CNVVF's ROE is +0.16%, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, CNVVF is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs SARTF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SARTF has a market cap of 16.5B. Regarding current trading prices, CNVVF is priced at $3.13, while SARTF trades at $212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SARTF's P/E ratio is 135.90. In terms of profitability, CNVVF's ROE is +0.16%, compared to SARTF's ROE of +0.05%. Regarding short-term risk, CNVVF and SARTF have similar daily volatility (0.00).
CNVVF vs SUVPF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SUVPF has a market cap of 15.4B. Regarding current trading prices, CNVVF is priced at $3.13, while SUVPF trades at $259.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SUVPF's P/E ratio is 167.11. In terms of profitability, CNVVF's ROE is +0.16%, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, CNVVF and SUVPF have similar daily volatility (0.00).
CNVVF vs OCPNF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, OCPNF has a market cap of 15.2B. Regarding current trading prices, CNVVF is priced at $3.13, while OCPNF trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas OCPNF's P/E ratio is 18.75. In terms of profitability, CNVVF's ROE is +0.16%, compared to OCPNF's ROE of +0.10%. Regarding short-term risk, CNVVF and OCPNF have similar daily volatility (0.00).
CNVVF vs FSPKF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, FSPKF has a market cap of 12.9B. Regarding current trading prices, CNVVF is priced at $3.13, while FSPKF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas FSPKF's P/E ratio is 122.22. In terms of profitability, CNVVF's ROE is +0.16%, compared to FSPKF's ROE of +0.10%. Regarding short-term risk, CNVVF and FSPKF have similar daily volatility (0.00).
CNVVF vs SSMXY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SSMXY has a market cap of 10.5B. Regarding current trading prices, CNVVF is priced at $3.13, while SSMXY trades at $16.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SSMXY's P/E ratio is 27.96. In terms of profitability, CNVVF's ROE is +0.16%, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, CNVVF is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs SSMXF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SSMXF has a market cap of 9.3B. Regarding current trading prices, CNVVF is priced at $3.13, while SSMXF trades at $14.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SSMXF's P/E ratio is 24.75. In terms of profitability, CNVVF's ROE is +0.16%, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, CNVVF and SSMXF have similar daily volatility (0.00).
CNVVF vs CNVVY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, CNVVY has a market cap of 8B. Regarding current trading prices, CNVVF is priced at $3.13, while CNVVY trades at $15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas CNVVY's P/E ratio is 42.42. In terms of profitability, CNVVF's ROE is +0.16%, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, CNVVF is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs CZMWF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, CZMWF has a market cap of 5.8B. Regarding current trading prices, CNVVF is priced at $3.13, while CZMWF trades at $65.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas CZMWF's P/E ratio is 32.73. In terms of profitability, CNVVF's ROE is +0.16%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, CNVVF and CZMWF have similar daily volatility (0.00).
CNVVF vs YPHDF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, YPHDF has a market cap of 5.7B. Regarding current trading prices, CNVVF is priced at $3.13, while YPHDF trades at $417.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas YPHDF's P/E ratio is 53.45. In terms of profitability, CNVVF's ROE is +0.16%, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, CNVVF is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs CZMWY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, CZMWY has a market cap of 5.7B. Regarding current trading prices, CNVVF is priced at $3.13, while CZMWY trades at $64.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas CZMWY's P/E ratio is 32.24. In terms of profitability, CNVVF's ROE is +0.16%, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, CNVVF is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs FLMNF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, FLMNF has a market cap of 5.3B. Regarding current trading prices, CNVVF is priced at $3.13, while FLMNF trades at $62.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas FLMNF's P/E ratio is 30.37. In terms of profitability, CNVVF's ROE is +0.16%, compared to FLMNF's ROE of +0.17%. Regarding short-term risk, CNVVF and FLMNF have similar daily volatility (0.00).
CNVVF vs FLMNY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, FLMNY has a market cap of 5.2B. Regarding current trading prices, CNVVF is priced at $3.13, while FLMNY trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas FLMNY's P/E ratio is 30.29. In terms of profitability, CNVVF's ROE is +0.16%, compared to FLMNY's ROE of +0.17%. Regarding short-term risk, CNVVF and FLMNY have similar daily volatility (0.00).
CNVVF vs ADDLF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, CNVVF is priced at $3.13, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, CNVVF's ROE is +0.16%, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, CNVVF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs AHICF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, AHICF has a market cap of 4.4B. Regarding current trading prices, CNVVF is priced at $3.13, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas AHICF's P/E ratio is 59.89. In terms of profitability, CNVVF's ROE is +0.16%, compared to AHICF's ROE of +0.07%. Regarding short-term risk, CNVVF and AHICF have similar daily volatility (0.00).
CNVVF vs TEVNF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TEVNF has a market cap of 3.2B. Regarding current trading prices, CNVVF is priced at $3.13, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TEVNF's P/E ratio is -0.21. In terms of profitability, CNVVF's ROE is +0.16%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, CNVVF and TEVNF have similar daily volatility (0.00).
CNVVF vs ANSLY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, CNVVF is priced at $3.13, while ANSLY trades at $83.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas ANSLY's P/E ratio is 25.72. In terms of profitability, CNVVF's ROE is +0.16%, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, CNVVF and ANSLY have similar daily volatility (0.00).
CNVVF vs SHWGF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SHWGF has a market cap of 3B. Regarding current trading prices, CNVVF is priced at $3.13, while SHWGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SHWGF's P/E ratio is 11.02. In terms of profitability, CNVVF's ROE is +0.16%, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, CNVVF and SHWGF have similar daily volatility (0.00).
CNVVF vs ANSLF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, ANSLF has a market cap of 2.6B. Regarding current trading prices, CNVVF is priced at $3.13, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, CNVVF's ROE is +0.16%, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, CNVVF and ANSLF have similar daily volatility (0.00).
CNVVF vs GRRMF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, GRRMF has a market cap of 2.5B. Regarding current trading prices, CNVVF is priced at $3.13, while GRRMF trades at $73.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas GRRMF's P/E ratio is 28.60. In terms of profitability, CNVVF's ROE is +0.16%, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, CNVVF and GRRMF have similar daily volatility (0.00).
CNVVF vs TCHBF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TCHBF has a market cap of 2.5B. Regarding current trading prices, CNVVF is priced at $3.13, while TCHBF trades at $200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TCHBF's P/E ratio is 31.06. In terms of profitability, CNVVF's ROE is +0.16%, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, CNVVF and TCHBF have similar daily volatility (0.00).
CNVVF vs TCGGY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TCGGY has a market cap of 2.2B. Regarding current trading prices, CNVVF is priced at $3.13, while TCGGY trades at $34.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TCGGY's P/E ratio is 26.84. In terms of profitability, CNVVF's ROE is +0.16%, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, CNVVF and TCGGY have similar daily volatility (0.00).
CNVVF vs EKTAY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, EKTAY has a market cap of 2B. Regarding current trading prices, CNVVF is priced at $3.13, while EKTAY trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas EKTAY's P/E ratio is 86.72. In terms of profitability, CNVVF's ROE is +0.16%, compared to EKTAY's ROE of +0.10%. Regarding short-term risk, CNVVF is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs EKTAF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, EKTAF has a market cap of 1.8B. Regarding current trading prices, CNVVF is priced at $3.13, while EKTAF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas EKTAF's P/E ratio is 83.33. In terms of profitability, CNVVF's ROE is +0.16%, compared to EKTAF's ROE of +0.10%. Regarding short-term risk, CNVVF and EKTAF have similar daily volatility (0.00).
CNVVF vs BOEUF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, BOEUF has a market cap of 1.7B. Regarding current trading prices, CNVVF is priced at $3.13, while BOEUF trades at $25.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas BOEUF's P/E ratio is 135.53. In terms of profitability, CNVVF's ROE is +0.16%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, CNVVF and BOEUF have similar daily volatility (0.00).
CNVVF vs NPRRF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, NPRRF has a market cap of 1.6B. Regarding current trading prices, CNVVF is priced at $3.13, while NPRRF trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas NPRRF's P/E ratio is 44.74. In terms of profitability, CNVVF's ROE is +0.16%, compared to NPRRF's ROE of N/A. Regarding short-term risk, CNVVF and NPRRF have similar daily volatility (0.00).
CNVVF vs TGLVY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TGLVY has a market cap of 1.5B. Regarding current trading prices, CNVVF is priced at $3.13, while TGLVY trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TGLVY's P/E ratio is 75.86. In terms of profitability, CNVVF's ROE is +0.16%, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, CNVVF and TGLVY have similar daily volatility (0.00).
CNVVF vs BITGF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, CNVVF is priced at $3.13, while BITGF trades at $14.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas BITGF's P/E ratio is 45.06. In terms of profitability, CNVVF's ROE is +0.16%, compared to BITGF's ROE of +0.06%. Regarding short-term risk, CNVVF and BITGF have similar daily volatility (0.00).
CNVVF vs PBHDF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, PBHDF has a market cap of 1.1B. Regarding current trading prices, CNVVF is priced at $3.13, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, CNVVF's ROE is +0.16%, compared to PBHDF's ROE of +0.06%. Regarding short-term risk, CNVVF and PBHDF have similar daily volatility (0.00).
CNVVF vs TDVXF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TDVXF has a market cap of 1.1B. Regarding current trading prices, CNVVF is priced at $3.13, while TDVXF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TDVXF's P/E ratio is 65.63. In terms of profitability, CNVVF's ROE is +0.16%, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, CNVVF and TDVXF have similar daily volatility (0.00).
CNVVF vs KSRBF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, KSRBF has a market cap of 866.4M. Regarding current trading prices, CNVVF is priced at $3.13, while KSRBF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas KSRBF's P/E ratio is 4.87. In terms of profitability, CNVVF's ROE is +0.16%, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, CNVVF is less volatile compared to KSRBF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs NNCSF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, NNCSF has a market cap of 865.3M. Regarding current trading prices, CNVVF is priced at $3.13, while NNCSF trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas NNCSF's P/E ratio is 95.00. In terms of profitability, CNVVF's ROE is +0.16%, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, CNVVF is less volatile compared to NNCSF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs SHWGY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SHWGY has a market cap of 788.6M. Regarding current trading prices, CNVVF is priced at $3.13, while SHWGY trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SHWGY's P/E ratio is 11.16. In terms of profitability, CNVVF's ROE is +0.16%, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, CNVVF and SHWGY have similar daily volatility (0.00).
CNVVF vs SPMXF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SPMXF has a market cap of 550.3M. Regarding current trading prices, CNVVF is priced at $3.13, while SPMXF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SPMXF's P/E ratio is -18.00. In terms of profitability, CNVVF's ROE is +0.16%, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, CNVVF and SPMXF have similar daily volatility (0.00).
CNVVF vs SAFLF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SAFLF has a market cap of 544.4M. Regarding current trading prices, CNVVF is priced at $3.13, while SAFLF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SAFLF's P/E ratio is 22.50. In terms of profitability, CNVVF's ROE is +0.16%, compared to SAFLF's ROE of +0.00%. Regarding short-term risk, CNVVF is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs JNDOF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, CNVVF is priced at $3.13, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, CNVVF's ROE is +0.16%, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, CNVVF is less volatile compared to JNDOF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs HGYMF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, HGYMF has a market cap of 510.1M. Regarding current trading prices, CNVVF is priced at $3.13, while HGYMF trades at $23.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas HGYMF's P/E ratio is 32.86. In terms of profitability, CNVVF's ROE is +0.16%, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, CNVVF is less volatile compared to HGYMF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs CLHLF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, CLHLF has a market cap of 455.6M. Regarding current trading prices, CNVVF is priced at $3.13, while CLHLF trades at $76.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas CLHLF's P/E ratio is 34.82. In terms of profitability, CNVVF's ROE is +0.16%, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, CNVVF is less volatile compared to CLHLF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs SAFLY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SAFLY has a market cap of 449.6M. Regarding current trading prices, CNVVF is priced at $3.13, while SAFLY trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SAFLY's P/E ratio is 223.00. In terms of profitability, CNVVF's ROE is +0.16%, compared to SAFLY's ROE of +0.00%. Regarding short-term risk, CNVVF is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs GUERF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, CNVVF is priced at $3.13, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas GUERF's P/E ratio is 8.19. In terms of profitability, CNVVF's ROE is +0.16%, compared to GUERF's ROE of N/A. Regarding short-term risk, CNVVF and GUERF have similar daily volatility (0.00).
CNVVF vs TSNLF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TSNLF has a market cap of 252.4M. Regarding current trading prices, CNVVF is priced at $3.13, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, CNVVF's ROE is +0.16%, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, CNVVF is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs OPSSF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, CNVVF is priced at $3.13, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, CNVVF's ROE is +0.16%, compared to OPSSF's ROE of -0.17%. Regarding short-term risk, CNVVF is less volatile compared to OPSSF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs MCDA Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, MCDA has a market cap of 212M. Regarding current trading prices, CNVVF is priced at $3.13, while MCDA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas MCDA's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to MCDA's ROE of N/A. Regarding short-term risk, CNVVF is less volatile compared to MCDA. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs EEOIF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, CNVVF is priced at $3.13, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, CNVVF's ROE is +0.16%, compared to EEOIF's ROE of N/A. Regarding short-term risk, CNVVF and EEOIF have similar daily volatility (0.00).
CNVVF vs UEEC Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, UEEC has a market cap of 53.5M. Regarding current trading prices, CNVVF is priced at $3.13, while UEEC trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas UEEC's P/E ratio is -20.82. In terms of profitability, CNVVF's ROE is +0.16%, compared to UEEC's ROE of +1.31%. Regarding short-term risk, CNVVF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs IMTH Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, IMTH has a market cap of 20.3M. Regarding current trading prices, CNVVF is priced at $3.13, while IMTH trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas IMTH's P/E ratio is -1.11. In terms of profitability, CNVVF's ROE is +0.16%, compared to IMTH's ROE of +2.29%. Regarding short-term risk, CNVVF is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs GVDI Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, GVDI has a market cap of 16.2M. Regarding current trading prices, CNVVF is priced at $3.13, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas GVDI's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, CNVVF is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs OTCFF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, OTCFF has a market cap of 10.8M. Regarding current trading prices, CNVVF is priced at $3.13, while OTCFF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas OTCFF's P/E ratio is -12.50. In terms of profitability, CNVVF's ROE is +0.16%, compared to OTCFF's ROE of +18.74%. Regarding short-term risk, CNVVF is less volatile compared to OTCFF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs OJSY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, OJSY has a market cap of 9.1M. Regarding current trading prices, CNVVF is priced at $3.13, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas OJSY's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to OJSY's ROE of N/A. Regarding short-term risk, CNVVF is less volatile compared to OJSY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs YBGJ Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, YBGJ has a market cap of 8M. Regarding current trading prices, CNVVF is priced at $3.13, while YBGJ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas YBGJ's P/E ratio is -3.35. In terms of profitability, CNVVF's ROE is +0.16%, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, CNVVF is less volatile compared to YBGJ. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs TUTH Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, TUTH has a market cap of 6.1M. Regarding current trading prices, CNVVF is priced at $3.13, while TUTH trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas TUTH's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to TUTH's ROE of N/A. Regarding short-term risk, CNVVF and TUTH have similar daily volatility (0.00).
CNVVF vs BLMHF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, CNVVF is priced at $3.13, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, CNVVF's ROE is +0.16%, compared to BLMHF's ROE of N/A. Regarding short-term risk, CNVVF and BLMHF have similar daily volatility (0.00).
CNVVF vs CBSC Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, CBSC has a market cap of 5.1M. Regarding current trading prices, CNVVF is priced at $3.13, while CBSC trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas CBSC's P/E ratio is -4.50. In terms of profitability, CNVVF's ROE is +0.16%, compared to CBSC's ROE of +1.52%. Regarding short-term risk, CNVVF and CBSC have similar daily volatility (0.00).
CNVVF vs PXMVF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, CNVVF is priced at $3.13, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, CNVVF's ROE is +0.16%, compared to PXMVF's ROE of N/A. Regarding short-term risk, CNVVF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs RSCF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, RSCF has a market cap of 4.6M. Regarding current trading prices, CNVVF is priced at $3.13, while RSCF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas RSCF's P/E ratio is -5.34. In terms of profitability, CNVVF's ROE is +0.16%, compared to RSCF's ROE of +0.08%. Regarding short-term risk, CNVVF is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs ECIA Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, ECIA has a market cap of 3.6M. Regarding current trading prices, CNVVF is priced at $3.13, while ECIA trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas ECIA's P/E ratio is -7.68. In terms of profitability, CNVVF's ROE is +0.16%, compared to ECIA's ROE of -0.33%. Regarding short-term risk, CNVVF is less volatile compared to ECIA. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs NSTGQ Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, CNVVF is priced at $3.13, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, CNVVF is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs REMI Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, REMI has a market cap of 419.9K. Regarding current trading prices, CNVVF is priced at $3.13, while REMI trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas REMI's P/E ratio is -2.10. In terms of profitability, CNVVF's ROE is +0.16%, compared to REMI's ROE of -0.08%. Regarding short-term risk, CNVVF and REMI have similar daily volatility (0.00).
CNVVF vs PDMI Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, CNVVF is priced at $3.13, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas PDMI's P/E ratio is -0.01. In terms of profitability, CNVVF's ROE is +0.16%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, CNVVF and PDMI have similar daily volatility (0.00).
CNVVF vs WHSI Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, CNVVF is priced at $3.13, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas WHSI's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, CNVVF and WHSI have similar daily volatility (0.00).
CNVVF vs QTXB Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, CNVVF is priced at $3.13, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas QTXB's P/E ratio is -0.05. In terms of profitability, CNVVF's ROE is +0.16%, compared to QTXB's ROE of +0.00%. Regarding short-term risk, CNVVF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs CEOS Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, CEOS has a market cap of 88.8K. Regarding current trading prices, CNVVF is priced at $3.13, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas CEOS's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to CEOS's ROE of +1.18%. Regarding short-term risk, CNVVF is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs SVSO Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SVSO has a market cap of 63.8K. Regarding current trading prices, CNVVF is priced at $3.13, while SVSO trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SVSO's P/E ratio is -0.17. In terms of profitability, CNVVF's ROE is +0.16%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, CNVVF is less volatile compared to SVSO. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs SDCCQ Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SDCCQ has a market cap of 40.3K. Regarding current trading prices, CNVVF is priced at $3.13, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, CNVVF and SDCCQ have similar daily volatility (0.00).
CNVVF vs LANZ Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, LANZ has a market cap of 27.7K. Regarding current trading prices, CNVVF is priced at $3.13, while LANZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas LANZ's P/E ratio is 1.00. In terms of profitability, CNVVF's ROE is +0.16%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, CNVVF and LANZ have similar daily volatility (0.00).
CNVVF vs GMVDF Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, CNVVF is priced at $3.13, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas GMVDF's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, CNVVF and GMVDF have similar daily volatility (0.00).
CNVVF vs VSMD Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, VSMD has a market cap of 22.4K. Regarding current trading prices, CNVVF is priced at $3.13, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas VSMD's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, CNVVF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs ASFX Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, ASFX has a market cap of 17.5K. Regarding current trading prices, CNVVF is priced at $3.13, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas ASFX's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, CNVVF and ASFX have similar daily volatility (0.00).
CNVVF vs MDIT Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, MDIT has a market cap of 17.2K. Regarding current trading prices, CNVVF is priced at $3.13, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas MDIT's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, CNVVF is less volatile compared to MDIT. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs INND Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, INND has a market cap of 14.5K. Regarding current trading prices, CNVVF is priced at $3.13, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas INND's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to INND's ROE of +0.32%. Regarding short-term risk, CNVVF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs LFPI Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, LFPI has a market cap of 10.2K. Regarding current trading prices, CNVVF is priced at $3.13, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas LFPI's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, CNVVF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs SECI Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SECI has a market cap of 9.2K. Regarding current trading prices, CNVVF is priced at $3.13, while SECI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SECI's P/E ratio is -0.18. In terms of profitability, CNVVF's ROE is +0.16%, compared to SECI's ROE of -0.00%. Regarding short-term risk, CNVVF is less volatile compared to SECI. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs DGEN Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, CNVVF is priced at $3.13, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas DGEN's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, CNVVF and DGEN have similar daily volatility (0.00).
CNVVF vs BLFE Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, BLFE has a market cap of 1.6K. Regarding current trading prices, CNVVF is priced at $3.13, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas BLFE's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to BLFE's ROE of +0.00%. Regarding short-term risk, CNVVF and BLFE have similar daily volatility (0.00).
CNVVF vs SEYE Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, CNVVF is priced at $3.13, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas SEYE's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to SEYE's ROE of N/A. Regarding short-term risk, CNVVF and SEYE have similar daily volatility (0.00).
CNVVF vs ADLI Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, CNVVF is priced at $3.13, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas ADLI's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, CNVVF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs HRAL Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, HRAL has a market cap of 396. Regarding current trading prices, CNVVF is priced at $3.13, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas HRAL's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to HRAL's ROE of +0.13%. Regarding short-term risk, CNVVF is less volatile compared to HRAL. This indicates potentially lower risk in terms of short-term price fluctuations for CNVVF.
CNVVF vs MICRD Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, MICRD has a market cap of 317. Regarding current trading prices, CNVVF is priced at $3.13, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas MICRD's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, CNVVF and MICRD have similar daily volatility (0.00).
CNVVF vs RGBOQ Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, CNVVF is priced at $3.13, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, CNVVF's ROE is +0.16%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, CNVVF and RGBOQ have similar daily volatility (0.00).
CNVVF vs BGMD Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, BGMD has a market cap of 11. Regarding current trading prices, CNVVF is priced at $3.13, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas BGMD's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to BGMD's ROE of +0.00%. Regarding short-term risk, CNVVF and BGMD have similar daily volatility (0.00).
CNVVF vs VTEQ Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, CNVVF is priced at $3.13, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, CNVVF's ROE is +0.16%, compared to VTEQ's ROE of N/A. Regarding short-term risk, CNVVF and VTEQ have similar daily volatility (0.00).
CNVVF vs OCPNY Comparison
CNVVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVVF stands at 6.4B. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, CNVVF is priced at $3.13, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVVF currently has a P/E ratio of 34.78, whereas OCPNY's P/E ratio is N/A. In terms of profitability, CNVVF's ROE is +0.16%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, CNVVF and OCPNY have similar daily volatility (0.00).